Protein structure prediction: On the route from sequence to function
As discussed in our previous blog post in this series, there is a large discrepancy between...
BioStrand Omics Analysis Blog:
AI
Scaling up structural biology with AlphaFold2
The unveiling of AlphaFold2 during the Critical Assessment of Structure Prediction (CASP) 14th...
Data-Driven Biomedical Research
Data-driven biomedical research is the foundation of effective precision medicine (PM). Of course,...
Exploring the microbiome's impact on immunotherapy efficacy
In our previous blog post (check it out here), we explored how the microbiota can have a profound...
The microbiome- immune axis: the intersection of science and medicine
Hippocrates was quoted as saying ‘all disease starts in the gut’ and over 2000 years later...
LENSai™ - biotherapeutic intelligence for precision drug development
The completion of the Human Genome Project in 2003 set the stage for the modern era in precision...
Creating an AI-ready data foundation for successful AI-enabled drug discovery
Over the past year, we have looked at drug discovery and development from several different...
Computational biology and drug discovery: what to expect in 2023
The year 2022 in computational biology was largely marked by two main advancements:
Our most widely read blogs from 2022
It’s been another momentous year for the global life sciences industry. Ever since the pandemic...
Notes from BioTechX 2022
I recently had the privilege of representing the BioStrand Team at BioTechX, Europe’s largest...
Key elements of successful AI-native drug discovery
The use of AI in drug discovery has been progressively expanding over the past decade. Over the...